問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
China Medical University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2007-05-01 - 2009-12-31
Condition/Disease
Test Drug
Participate Sites11Sites
Study ended11Sites
2005-12-01 - 2007-12-01
Participate Sites10Sites
Study ended10Sites
2006-12-18 - 2010-09-07
Participate Sites13Sites
Terminated13Sites
2015-10-02 - 2019-03-31
Hypercholesterolemia and Hyperlipidemia
Hocena®
Participate Sites6Sites
Terminated6Sites
2018-01-01 - 2020-12-31
Participate Sites2Sites
Not yet recruiting2Sites
2016-06-01 - 2025-05-31
Triple Negative Locally Advanced Breast Cancer
atezolizumab (MPDL3280A)
Participate Sites7Sites
Terminated5Sites
Division of General Surgery
未分科
2018-07-31 - 2020-01-31
Overactive Bladder
Uritos
Participate Sites12Sites
Terminated11Sites
2014-10-01 - 2024-12-30
PROSTATE CANCER
MCS®
Participate Sites21Sites
Recruiting6Sites
Study ended15Sites
Participate Sites4Sites
Terminated4Sites
2011-09-30 - 2013-09-30
全部